RNA Analysis Market (By Technology: Real Time-PCR (qPCR) Technology, Microarray Technology, Sequencing Technology; By Product: Instruments, Kits & Reagents, Services; By Application: Construction of RNA Expression Atlas, Epigenetics, Infectious Diseases and Pathogenesis, Alternative RNA Splicing, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics; By End-use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Application Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global RNA Analysis Market, By Technology

7.1.  RNA Analysis Market, by Technology, 2021-2030

7.1.1.    Real Time-PCR (qPCR) Technology

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Microarray Technology

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Sequencing Technology

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global RNA Analysis Market, By Product

8.1.  RNA Analysis Market, by Product, 2021-2030

8.1.1.    Instruments

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Kits & Reagents

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Services

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global RNA Analysis Market, By Application

9.1.  RNA Analysis Market, by Application, 2021-2030

9.1.1.    Construction of RNA Expression Atlas

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Epigenetics

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Infectious Diseases and Pathogenesis

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Alternative RNA Splicing

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    RNA Structure & Molecular Dynamics

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Development & Delivery of RNA Therapeutics

9.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global RNA Analysis Market, By End-use

10.1.        RNA Analysis Market, by End-use, 2021-2030

10.1.1.  Government Institutes & Academic Centers

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Pharmaceutical & Biotechnology Companies

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Contract Research Organizations (CROs)

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Hospitals & Clinics

10.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global RNA Analysis Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.1.2.  Market Revenue and Forecast, by Product (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.2.2.  Market Revenue and Forecast, by Product (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.3.2.  Market Revenue and Forecast, by Product (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.4.2.  Market Revenue and Forecast, by Product (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Technology (2017-2030)

11.5.2.  Market Revenue and Forecast, by Product (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Technology (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              Agilent Technologies, Inc.

12.1.1.  Company Overview

12.1.2.  Technology Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              F. Hoffmann-La Roche AG

12.2.1.  Company Overview

12.2.2.  Technology Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Illumina, Inc.

12.3.1.  Company Overview

12.3.2.  Technology Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              QIAGEN

12.4.1.  Company Overview

12.4.2.  Technology Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Thermo Fisher Scientific, Inc.

12.5.1.  Company Overview

12.5.2.  Technology Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Eurofins Scientific

12.6.1.  Company Overview

12.6.2.  Technology Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Merck KGaA

12.7.1.  Company Overview

12.7.2.  Technology Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Bio-Rad Laboratories, Inc.

12.8.1.  Company Overview

12.8.2.  Technology Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Pacific Bioscience of California, Inc.

12.9.1.  Company Overview

12.9.2.  Technology Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Affymetrix, Inc.

12.10.1.               Company Overview

12.10.2.               Technology Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms